Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
I heard what she said but didn’t quite get it. Her observation didn’t sink in, and wouldn’t sink in until years later.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results